Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Magnetic fluid hyperthermia (MFH) uses magnetic nanoparticles (MNPs) to generate heat for cancer therapy.
• Hyperthermia induces cell death or damage based on localized temperature increases.
• Optimizing MNP properties is crucial for enhancing MFH therapeutic outcomes.

Purpose of the Study:

• To investigate the therapeutic effect of MFH on Jurkat T lymphocyte cells.
• To evaluate the impact of MNP size on heating efficiency and cell viability.
• To demonstrate the importance of tailoring MNP size for specific frequencies to improve MFH potency.

Main Methods:

• Synthesis of monodisperse magnetite (Fe(3)O(4)) nanoparticles (MNPs) with varying sizes (∼12-16 nm).
• Transfer of MNPs to an aqueous phase using a biocompatible amphiphilic polymer.
• In vitro hyperthermia treatment of Jurkat cells using MNPs under an alternating magnetic field (373 kHz).
• Assessment of cell viability and heating efficiency (specific loss power) based on MNP size and dose.

Main Results:

• Size-optimized MNPs (∼16 nm) exhibited maximum heating efficiency at 373 kHz.
• A lower dose (490 μg Fe/ml) of 16 nm MNPs resulted in 40% cell survival after 15 min of heating.
• Larger MNP sizes (12-13 nm) at higher doses (600 μg Fe/ml) showed significantly higher cell survival rates (80-90%).

Conclusions:

• Tailoring MNP size to specific frequencies is critical for maximizing MFH therapeutic efficacy.
• Size-optimized MNPs significantly enhance cell killing potential, allowing for lower doses and shorter treatment times.
• This study highlights the potential of optimizing MNP size for improved MFH treatment strategies in cancer therapy.